Target intelligence / Profile preview

Voltage-gated ion channel superfamily (VGIC)

Target
VGIC
Molecular classification
Ion channel, Voltage-gated ion channel superfamily
01

Overview

Voltage-gated sodium, potassium, and calcium channels are the primary members of the voltage-gated ion channel (VGIC) superfamily, which are critical for the generation and propagation of electrical signals in excitable cells such as neurons and myocytes [1][2]. These channels are transmembrane proteins that open their ion-selective pores in response to changes in the membrane potential, allowing specific ions to flow down their electrochemical gradients [1]. Voltage-gated sodium channels (Nav) initiate the rapid depolarization phase of the action potential, while voltage-gated potassium channels (Kv) are responsible for the repolarization phase and maintaining the resting membrane potential [2][3]. Voltage-gated calcium channels (Cav) serve as essential links between electrical excitation and intracellular signaling, triggering processes like muscle contraction, neurotransmitter release, and gene expression [1][3]. Because of their fundamental roles, these channels are major therapeutic targets for a wide range of drugs, including local anesthetics, anti-epileptics, anti-arrhythmics, and antihypertensives [3]. Dysfunctions in these channels, often due to genetic mutations, lead to various channelopathies such as epilepsy, cardiac arrhythmias (e.g., Long QT syndrome), and periodic paralysis [2].

Other names
Voltage-dependent ion channelsVoltage-gated sodium channels (Nav)Voltage-gated potassium channels (Kv)Voltage-gated calcium channels (Cav)VGSCsVGKCsVGCCs
02

Mechanism of action

Drugs targeting these channels typically act as pore blockers, gating modifiers, or allosteric modulators to either inhibit or enhance ion conductance, thereby altering cellular excitability and signaling [1][3].

03

Biological functions

Action potential generationAction potential propagationMembrane repolarizationExcitation-contraction couplingNeurotransmitter releaseSignal transduction
04

Disease associations

EpilepsyCardiac arrhythmiaHypertensionChronic painPeriodic paralysisNeuropathic painBrugada syndromeLong QT syndrome
05

Safety considerations

Cardiac arrhythmias (e.g., Torsades de Pointes)Central nervous system toxicity (e.g., seizures, ataxia)HypotensionNegative inotropy
06

Interacting drugs

Lidocaine

12 more in the full profile.

07

Biomarkers

Electrocardiogram (ECG) parameters (e.g., QRS duration, QT interval)Blood pressureGenetic variants in SCN, KCN, or CACNA gene families

Beyond the preview

Go deeper on Voltage-gated ion channel superfamily (VGIC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated ion channel superfamily (VGIC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call